Zacks Investment ResearchThu, 19 Mar 2026 17:01:10 GMTAdlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's WhyANL-3.07%
Zacks Investment ResearchMon, 09 Mar 2026 14:41:48 GMTIs Adlai Nortye Ltd. Sponsored ADR (ANL) Outperforming Other Medical Stocks This Year?ANL-3.07%
Zacks Investment ResearchThu, 19 Feb 2026 15:41:34 GMTHas Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year?ANL-3.07%